Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DTwP-Hepatitis B-Hib-IPV
- Development stage
- Unknown
- Lead developer
- Bio Farma
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
DTwP-Hepatitis B-Hib-IPV is a hexavalent combination vaccine developed by Bio Farma. It is designed to provide active immunization against six infectious diseases: Diphtheria, Tetanus, Pertussis (whooping cough), Hepatitis B, *Haemophilus influenzae* type b (Hib) disease, and Poliomyelitis. The vaccine contains diphtheria and tetanus toxoids, whole-cell pertussis antigens, Hepatitis B surface antigen, *Haemophilus influenzae* type b capsular polysaccharide conjugated to a carrier protein, and inactivated poliovirus types 1, 2, and 3. It works by stimulating the immune system to produce protective antibodies against these pathogens.
- Other names
- Hexavalent DTwP-HepB-Hib-IPV vaccineBio Farma hexavalent vaccineDTwP-Hepatitis B-Hib-IPV Vaccine Formula ADTwP-Hepatitis B-Hib-IPV Vaccine Formula B
02
Targets
Adaptive immune receptors/cells recognizing hepatitis B surface antigenBCR (Immunoglobulin G B Cell Receptor)Adaptive immune receptors/cells recognizing inactivated poliovirus type 3 antigenIPV2 (Inactivated poliovirus type 2)Adaptive immune receptors/cells recognizing diphtheria toxoid antigen
Beyond the preview
Go deeper on DTwP-Hepatitis B-Hib-IPV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DTwP-Hepatitis B-Hib-IPV.